# Mel-Frontier

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mel-frontier

- Industry: Medical Devices & Equipment
- Headquarters: Tokyo, Japan
- Website: https://mel-frontier.jp/
- Total disclosed funding: $1.3M
- Latest round: Seed (Oct 16, 2020)
- Investors on record: 2

## About

Based in Japan, established in 2017, Mel-Frontier is a start-up based on the National Institute of Advanced Industrial Science and Technology's developed magnesium alloy parts and parts processing technology. In October of the same year, it received the title of AIST Technology Transfer Venture from AIST, and received various incentives based on the AIST Venture Technology Transfer Promotion Measures Implementation Regulations. 
The company, at present, uses Japan's highest standard magnesium alloy processing technology and proceeds with the development of bioabsorbable equipment. Also, it is proceeding with the development of new medical equipment that aims to improve the QOL of university hospitals and medical personnel.

Mg alloy that can be used in biomedical applications (FAsorbMg), Mel-frontier's alloy is balanced in bio-absorbability and mechanical characteristics. High-quality and accuracy Mg alloy components for medical device applications. Development of Mg-based medical devices with bio-absorbability and biocompatibility. Devices:Bone screws and plates, stent for coronary, biliary, and trachea etc, staple for anastomosis and others with biodegradable concepts. 

Bioabsorbable devices are low-invasive and absorbed in the human body for a specific period. There is no need to remove the implanted device, it has excellent biocompatibility, and little stress-shield effects.

## Funding rounds

- Seed, Oct 16, 2020, $1.3M — Tsukuba Institute of Research, SRD Holdings

## Investors

- Tsukuba Institute of Research (https://capitalatlas.ai/funds/tsukuba-institute-of-research) — Seed
- SRD Holdings — Seed